Search Results
Mar 23, 2026, 08:50 ET Abbott completes acquisition of Exact Sciences
healthABBOTT PARK, Ill., March 23, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) today announced it has completed the acquisition of Exact Sciences, establishing Abbott as a leader in fast-growing cancer screening and diagnostics
More news about: Abbott
Mar 20, 2026, 09:00 ET Abbott acquisition of Exact Sciences set to close on March 23, 2026
peopleABBOTT PARK, Ill., March 20, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that it expects to close the acquisition of Exact Sciences on Monday, March 23, 2026. The announcement follows receipt of all regulatory
More news about: Abbott
Mar 18, 2026, 09:00 ET Vila Sésamo e Abbott lançam recursos no Brasil para ajudar crianças e famílias a desenvolverem hábitos saudáveis desde cedo
18 de março de 2026 /PRNewswire/ -- A Sesame Workshop, organização global sem fins lucrativos responsável pela Vila Sésamo, e a Abbott (NYSE: ABT), empresa global de cuidados para a saúde, anunciam um novo programa no Brasil criado para ajudar famílias a desenvolverem rotinas saudáveis relacionadas
More news about: Abbott
Mar 12, 2026, 08:00 ET Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve glucose management
population3ABBOTT PARK, Ill., March 12, 2026 /PRNewswire/ -- Abbott (NYSE: ABT), a global healthcare leader, today announced results from the FreeDM2 randomized controlled trial (RCT) showing that people using FreeStyle Libre continuous
More news about: Abbott
Mar 12, 2026, 04:54 ET Studie zeigt: FreeStyle Libre Technologie verhilft Menschen mit Typ-2-Diabetes und Basalinsulin zu einem besseren Glukosemanagement
ABBOTT PARK, Illinois, 12. März 2026 /PRNewswire/ -- Das Gesundheitsunternehmen Abbott (NYSE: ABT) hat heute Ergebnisse der randomisierten kontrollierten Studie (RCT) FreeDM2 vorgestellt. Die Daten zeigen, dass Personen, die die FreeStyle Libre Technologie
More news about: Abbott
Mar 12, 2026, 03:00 ET Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve glucose management
population3ABBOTT PARK, Ill., March 12, 2026 /PRNewswire/ -- Abbott (NYSE: ABT), a global healthcare leader, today announced results from the FreeDM2 randomized controlled trial (RCT) showing that people using FreeStyle Libre continuous
More news about: Abbott
Mar 11, 2026, 11:00 ET Abbott and Real Madrid launch nationwide effort to build the next 'Abbott Dream Team'
AbbottDreamTeam.comABBOTT PARK, Ill., March 11, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) announced today the launch of the second year of the 'Abbott Dream Team,' encouraging young soccer players aged 18–19 across the United States to sign
More news about: Abbott
Feb 24, 2026, 09:00 ET ASUS Republic of Gamers and KOJIMA PRODUCTIONS Team Up to Deliver a Brand-New Stunning Lineup of Gamer Gear
AbtPricing:ROG Flow Z13-KJP: $3,699.99ROG Delta II-KJP: $269.99ROG Keris II Origin-KJP: $169.99ROG Scabbard II-KJP:
More news about: ASUS Computer International
Feb 20, 2026, 11:38 ET Abbott declares 409th consecutive quarterly dividend
ABBOTT PARK, Ill., Feb. 20, 2026 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 63 cents per share. This marks the 409th consecutive quarterly dividend to be paid by
More news about: Abbott
Feb 20, 2026, 02:00 ET U.S. Food and Drug Administration (FDA) Approves Combination Treatment of VENCLEXTA® (venetoclax) and Acalabrutinib for Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL)
developments, except as required by law.References:Study of Acalabrutinib (ACP-196) in Combination With Venetoclax (ABT-199), With and Without Obinutuzumab (GA101) Versus Chemoimmunotherapy for Previously Untreated CLL (AMPLIFY). Available at:
More news about: AbbVie
Feb 06, 2026, 08:00 ET Late-breaking data presentations showcase the safety and efficacy of Abbott's ablation catheters to treat people with atrial fibrillation
cases2ABBOTT PARK, Ill., Feb. 6, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) today announced new clinical data from two late-breaking presentations at AF Symposium in Boston (February 5-7, 2026) that demonstrate the strong safety
More news about: Abbott
Jan 22, 2026, 07:30 ET Abbott Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Financial Outlook
midpointABBOTT PARK, Ill., Jan. 22, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the fourth quarter ended Dec. 31, 2025. Fourth-quarter sales increased 4.4 percent on
More news about: Abbott
Jan 20, 2026, 09:00 ET Abbott receives CE Mark for the TactiFlex™ Duo Ablation Catheter to treat patients with abnormal heart rhythms
yearABBOTT PARK, Ill., Jan. 20, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) today announced it has received CE Mark in Europe for the TactiFlex™ Duo Ablation Catheter, Sensor Enabled™ to treat patients with atrial fibrillation
More news about: Abbott
Jan 16, 2026, 14:02 ET Exact Sciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Exact Sciences Corporation - EXAS
Exact Sciences Corporation (NasdaqCM: EXAS) to Abbott Laboratories (NYSE: ABT). Under the terms of the proposed transaction, shareholders of Exact Sciences will receive $105.00 in cash for each share of Exact Sciences that they
More news about: Kahn Swick & Foti, LLC
Jan 13, 2026, 10:02 ET Haier Hosts a Global Premium Sports Event in Saudi Arabia, Celebrating Innovation and Shared Passion
quality.Refrigerators support healthy diets with HCS Freshness Technology, keeping fruits and vegetables for up to 7 days without dehydration, while T•ABT Sterilization removes 99.9% of bacteria.Gaming TVs feature 120Hz high refresh rates for smoother visuals with minimal blur and tearing,
More news about: Haier
Jan 06, 2026, 13:09 ET Stena RoRo enters into a 5 year charter contract with Marine Atlantic, Canada
specifications:Length Over all: 203.24 mWidth: 25.7 mNo of Passengers: abt. 1200Cargo capacity: 1,920 cargo lane metersIce Class: 1A Speed: abt. 22 knBuild year: 2002Photo: A Nepita in current charter to Corsica LineaFor
More news about: Stena RoRo
Jan 06, 2026, 13:03 ET Stena RoRo enters into a 5 year charter contract with Marine Atlantic, Canada
specifications:Length Over all: 203.24 mWidth: 25.7 mNo of Passengers: abt. 1200Cargo capacity: 1,920 cargo lane metersIce Class: 1A Speed: abt. 22 knBuild year: 2002Photo: A Nepita in current charter to Corsica LineaFor
More news about: Stena RoRo
Jan 05, 2026, 16:30 ET Abbott hosts conference call for fourth-quarter earnings
ABBOTT PARK, Ill., Jan. 5, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its fourth-quarter 2025 financial results on Thursday, Jan. 22, before the market opens. The announcement will be followed by a live webcast
More news about: Abbott
Jan 05, 2026, 09:05 ET Abbott's new Libre Assist app feature tackles a top need for people living with diabetes: in-the-moment food decisions
2026ABBOTT PARK, Ill., Jan. 5, 2026 /PRNewswire/ -- Abbott (NYSE: ABT), a leading healthcare company, today unveiled
More news about: Abbott
Dec 22, 2025, 09:00 ET Abbott's Volt™ Pulsed Field Ablation System Receives FDA Approval to Treat Patients with Atrial Fibrillation
resultsABBOTT PARK, Ill., Dec. 22, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) today announced the U.S. Food and Drug Administration (FDA) has approved the company's Volt™ PFA System to treat patients battling atrial fibrillation
More news about: Abbott
Dec 18, 2025, 09:00 ET Abbott's Amplatzer Piccolo™ Delivery System Receives FDA Clearance and CE Mark to Optimize Procedures for Premature Babies With a Hole in the Heart
infants1ABBOTT PARK, Ill., Dec. 18, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) today announced it has received U.S. Food and Drug Administration (FDA) clearance and CE Mark for its Amplatzer Piccolo™ Delivery System, which is used
More news about: Abbott
Dec 15, 2025, 07:00 ET RedHill Biopharma's Positive Opaganib Results Indicate Reduction in Venetoclax Resistant Cells
Fernández-Grecco H, Bezares RF, Custidiano MDR, Sánchez-Ávalos JC, Vicente Á, Garate GM, Borge M, Giordano M, Gamberale R. Autologous T-cell activation fosters ABT-199 resistance in chronic lymphocytic leukemia: rationale for a combined therapy with SYK inhibitors and anti-CD20 monoclonal antibodies. Haematologica.
More news about: RedHill Biopharma Ltd.
Dec 12, 2025, 10:26 ET Abbott increases quarterly dividend for 54th consecutive year
1924ABBOTT PARK, Ill., Dec. 12, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that its board of directors has increased the company's quarterly common dividend to 63 cents per share, an increase of 6.8%. The company's
More news about: Abbott
Dec 12, 2025, 09:49 ET AI Diagnostics Hit Critical Mass as Hospitals Race to Cut Costs
VPTDF), Heartflow, Inc. (NASDAQ: HTFL), CeriBell, Inc. (NASDAQ: CBLL), Medtronic plc (NYSE: MDT), and Abbott Laboratories (NYSE: ABT).
More news about: USA News Group
Dec 08, 2025, 09:00 ET Abbott's Lingo™ Now on Android™, Expanding Access to Real-Time Glucose Data
conditions ABBOTT PARK, Ill., Dec. 8, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that
More news about: Abbott